CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $20.10 | $33K | 119,709 |
| 2024-02-15 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $18.37 | $31K | 121,375 |
| 2024-02-14 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −1,405 | $17.79 | $25K | 143,605 |
| 2024-02-14 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −20,128 | $17.66 | $355K | 187,341 |
| 2024-02-13 | Krognes Steve E. Director | Sale | −2,750 | $17.29 | $48K | 139,841 |
| 2024-02-13 | Watts Ryan J. President and CEO | Sale | −9,589 | $17.29 | $166K | 238,067 |
| 2024-02-13 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,784 | $17.29 | $48K | 145,010 |
| 2024-02-13 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −2,716 | $17.29 | $47K | 207,469 |
| 2024-02-08 | Schuth Alexander O. COFO and Secretary | Option exercise | +50,000 | $0.68 | $34K | 210,185 |
| 2024-02-08 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −50,000 | 145,078 | ||
| 2024-01-16 | SATO VICKI L Director | Sale 10b5-1 | −1,666 | $18.42 | $31K | 123,041 |
| 2024-01-10 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −4,668 | $19.02 | $89K | 147,794 |
| 2024-01-09 | Watts Ryan J. President and CEO | Sale | −7,818 | $19.78 | $155K | 2,268,363 |
| 2024-01-05 | Ho Carole Chief Medical Officer | Sale | −9,972 | $19.43 | $194K | 198,777 |
| 2024-01-05 | Krognes Steve E. Director | Sale | −3,208 | $19.43 | $62K | 142,591 |
| 2024-01-05 | Schuth Alexander O. COFO and Secretary | Sale | −9,972 | $19.43 | $194K | 539,307 |
| 2024-01-05 | Watts Ryan J. President and CEO | Sale | −17,483 | $19.43 | $340K | 2,276,181 |
| 2024-01-03 | Schuth Alexander O. COFO and Secretary | Grant or award | +53,720 | 170,157 | ||
| 2024-01-03 | Schuth Alexander O. COFO and Secretary | Grant or award · Stock Option (right to buy) | +161,160 | 161,160 | ||
| 2024-01-03 | Ho Carole Chief Medical Officer | Grant or award | +53,720 | 162,434 |
Page 8 of 53 · 1,043 trades